Updates are available Correction dated 2025-07-10
Click to view Correction: https://doi.org/10.1038/s42003-025-08481-2
-
Authors
Baylot, Virginie https://orcid.org/0000-0003-1313-2857
Le, Thi Khanh https://orcid.org/0000-0003-1883-0371
Taïeb, David
Rocchi, Palma
Colleaux, Laurence
-
Funding
Funding for this research was provided by:
Fondation de France (0131140/WB-2022-44423)
- License Information
-
More Information
Article History
Received: 22 August 2023
Accepted: 28 March 2024
First Online: 23 April 2024
Change Date: 10 July 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42003-025-08481-2
Competing interests
: P. Rocchi, D. Taieb and L. Colleaux are cofounders of SilonTx (), a biotech company started in April 2024 focusing on precision medicine and nucleic acid therapeutics. The other authors declare no competing interests.
